From the Desk of the CEO

Ear disorders affect pediatric and geriatric patients with greater frequency than other patients.

Daniel L. Krinsky, RPh, MS

Oriahnn (AbbVie) is the first and only FDA-approved oral treatment for the management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women.

Maria G. Tanzi, PharmD

Updates from FDA

The scientific evidence supporting healthy lifestyle habits for disease prevention and treatment is coming into focus.

Loren Bonner

On April 8, FDA, recognizing the increased demand for albuterol products during the novel coronavirus pandemic, approved the first generic albuterol inhaler.

Cara Aldridge Young